Nektar Therapeutics Deferred Tax Assets, Deferred Income
Nektar Therapeutics (NKTR) had Deferred Tax Assets, Deferred Income of $1.91 million as of 2019-12-31, per its 10-K filed 2020-02-28.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2020-02-28
- 2019-12-31: Deferred Tax Assets, Deferred Income $1.91M.
- 2018-12-31: Deferred Tax Assets, Deferred Income $4.47M.
- 2017-12-31: Deferred Tax Assets, Deferred Income $3.80M.
- 2016-12-31: Deferred Tax Assets, Deferred Income $23.04M.
| Period end | Deferred Tax Assets, Deferred Income |
|---|---|
| 2019-12-31 | $1.91M 10-K · filed 2020-02-28 |
| 2018-12-31 | $4.47M 10-K · filed 2020-02-28 |
| 2017-12-31 | $3.80M 10-K · filed 2019-03-01 |
| 2016-12-31 | $23.04M 10-K · filed 2018-03-01 |
| 2015-12-31 | $29.66M 10-K · filed 2017-03-01 |
| 2014-12-31 | $29.76M 10-K · filed 2016-02-29 |
| 2013-12-31 | $35.59M 10-K · filed 2015-02-26 |
| 2012-12-31 | $39.52M 10-K · filed 2014-02-27 |
| 2011-12-31 | $48.73M 10-K · filed 2013-03-01 |
| 2010-12-31 | $31.41M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |